0001420506-17-000048.txt : 20170127
0001420506-17-000048.hdr.sgml : 20170127
20170127114627
ACCESSION NUMBER: 0001420506-17-000048
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170127
DATE AS OF CHANGE: 20170127
EFFECTIVENESS DATE: 20170127
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC
CENTRAL INDEX KEY: 0001020455
IRS NUMBER: 133087622
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-05883
FILM NUMBER: 17552489
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2127516677
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: RHO MANAGEMENT CO INC
DATE OF NAME CHANGE: 19960806
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001020455
XXXXXXXX
12-31-2016
12-31-2016
false
RHO CAPITAL PARTNERS INC
152 WEST 57TH STREET
23RD FLOOR
NEW YORK
NY
10019
13F HOLDINGS REPORT
028-05883
N
Peter E. Kalkanis
Chief Financial Officer
2127516677
Peter E. Kalkanis, Chief Financial Officer
NEW YORK
NY
01-25-2017
0
5
130522
false
INFORMATION TABLE
2
Form13F_InfoTable.xml
INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC
CARA THERAPEUTICS INC
COM
140755109
28502
3068057
SH
SOLE
3068057
0
0
INOTEK PHARMACEUTICALS CORP
COM
45780V102
16030
2627790
SH
SOLE
2627790
0
0
INTRALINKS HLDGS INC
COM
46118H104
85048
6290503
SH
SOLE
6290503
0
0
RUBICON PROJ INC
COM
78112V102
380
51231
SH
SOLE
51231
0
0
SENSEONICS HLDGS INC
COM
81727U105
562
210342
SH
SOLE
210342
0
0